Med2Date — Clinical Guidelines
Home Rheumatology Carpal Tunnel Syndrome

Carpal Tunnel Syndrome

Last updated 12 May 2026 · Soft tissue / nerve
🎧 Carpal Tunnel Syndrome — deep-dive podcast

📋 Key Information Summary

📋
  • Definition: Carpal Tunnel Syndrome (CTS) is a common compressive neuropathy caused by increased pressure on the median nerve within the carpal tunnel.
  • Epidemiology: Affects 3-6% of adults in Australia; more common in women, dominant hand, and with increasing age.
  • Key Risk Factors: Female sex, pregnancy, obesity, diabetes mellitus, hypothyroidism, rheumatoid arthritis, and repetitive wrist movements.
  • Diagnosis: Primarily clinical, supported by characteristic symptoms (nocturnal paraesthesia, hand clumsiness) and provocative tests (Tinel's, Phalen's). Nerve conduction studies (NCS) confirm diagnosis and quantify severity.
  • First-Line Management: Conservative measures including nocturnal wrist splints and activity modification.
  • Pharmacotherapy: Ultrasound-guided corticosteroid injection (e.g., methylprednisolone) provides short-to-medium term symptom relief. Not a definitive cure.
  • Referral for NCS: Indicated for diagnostic uncertainty, failed conservative treatment, or when surgery is considered. MBS item 11000 (standard) or 11003 (with F-wave) available.
  • Surgical Indications: Persistent symptoms despite conservative therapy, thenar muscle atrophy/wasting, or severe NCS findings.
  • Surgical Options: Open or endoscopic carpal tunnel release. Both are effective; choice depends on surgeon expertise and patient factors.
  • Special Populations: Pregnancy-related CTS often resolves postpartum. Manage conservatively. In diabetes and rheumatoid arthritis, treat underlying condition concurrently.
  • ATSI Considerations: Higher prevalence of diabetes and obesity may increase CTS risk. Ensure equitable access to specialist and surgical services.
Carpal Tunnel Syndrome clinical infographic — pathophysiology, clinical clues, diagnosis, imaging, and management
Tap or click image to enlarge — Carpal Tunnel Syndrome: pathophysiology, clinical clues, diagnosis, imaging, and management.
Carpal Tunnel Syndrome infographic, full size
🎬 Carpal Tunnel Syndrome — clinical explainer

Introduction & Australian Epidemiology

Carpal Tunnel Syndrome (CTS) is the most common entrapment neuropathy, resulting from compression of the median nerve as it passes through the rigid carpal tunnel in the wrist. It is a significant cause of hand pain, numbness, and functional impairment in the working-age population.

In Australia, CTS has a lifetime prevalence estimated at 3-6%. It disproportionately affects women (female-to-male ratio approximately 3:1), with peak incidence between ages 40 and 60. Data from the Australian Institute of Health and Welfare (AIHW) indicates CTS as a leading cause of work-related musculoskeletal disorder, particularly in occupations involving repetitive wrist flexion, forceful grip, and vibration exposure. The condition imposes a substantial burden through lost productivity, healthcare utilisation, and workers' compensation claims.

Median Nerve Anatomy & Risk Factors

Anatomy

The carpal tunnel is a narrow, osteofibrous passageway located at the volar aspect of the wrist. Its boundaries are the carpal bones (floor and walls) and the transverse carpal ligament (flexor retinaculum) forming the roof. The tunnel contains nine digital flexor tendons and the median nerve. The median nerve provides sensory innervation to the palmar aspects of the lateral 3½ fingers (thumb, index, middle, radial half of ring finger) and motor innervation to the thenar muscles (opponens pollicis, abductor pollicis brevis, superficial head of flexor pollicis brevis).

Risk Factors

Risk factors increase the volume of contents within the tunnel or decrease the size of the tunnel itself.

Category Specific Factors
Anatomical Female sex (smaller tunnel cross-section), wrist fractures (Colles'), dislocations, acromegaly
Physiological / Hormonal Pregnancy, menopause, hypothyroidism, renal failure (dialysis amyloidosis), obesity
Inflammatory / Systemic Rheumatoid arthritis, gout, diabetes mellitus (endoneurial oedema)
Occupational / Activity Repetitive wrist flexion/extension, forceful grip, use of vibrating tools (controversial but frequently cited)

Clinical Assessment

Diagnosis is primarily clinical, based on characteristic history and examination findings.

History

  • Symptoms: Numbness, tingling (paraesthesia), burning pain in the median nerve distribution. Often worse at night or with activities like driving, reading, or holding a phone.
  • Nocturnal Symptoms: A hallmark feature. Patients may report waking with a "dead hand" needing to shake or wring it to relieve symptoms.
  • Clumsiness: Difficulty with fine motor tasks (buttons, dropping objects) due to sensory loss or thenar weakness.

Physical Examination

  • Sensory: Test light touch and two-point discrimination over the median nerve territory. Check for sensory deficit.
  • Motor: Assess thumb opposition and abduction strength. Look for thenar muscle flattening (atrophy) in advanced cases.
  • Provocative Tests:
    • Tinel's Sign: Tapping over the carpal tunnel at the wrist. A positive test reproduces paraesthesia in the median nerve distribution. Sensitivity ~50%, Specificity ~77%.
    • Phalen's Test: Patient holds wrists in full flexion for 60 seconds. A positive test reproduces symptoms. Sensitivity ~68%, Specificity ~73%.
    • Carpal Tunnel Compression Test: Direct pressure over the carpal tunnel for 30 seconds. High sensitivity (~89%).
⚠️
Red Flags: Thenar atrophy, constant numbness, significant weakness, or symptoms outside the median nerve distribution warrant urgent neurological evaluation and NCS to exclude other diagnoses (e.g., cervical radiculopathy, polyneuropathy).

Nerve Conduction Studies (NCS)

Nerve conduction studies (NCS) and electromyography (EMG) are the gold standard for confirming the diagnosis of CTS, localising the lesion, and grading its severity. They are crucial when the diagnosis is uncertain, symptoms are severe, or surgical intervention is planned.

Role and Indications

  • Diagnostic Confirmation: Differentiates CTS from mimics like cervical radiculopathy or generalised polyneuropathy.
  • Severity Grading: Guides prognosis and treatment choices (e.g., mild CTS may respond to splints; severe CTS may require surgery).
  • Surgical Planning: Provides objective baseline data and confirms the diagnosis prior to decompression.

Key Findings in CTS

  • Sensory: Prolonged sensory distal latency and reduced sensory nerve action potential (SNAP) amplitude across the wrist.
  • Motor: Prolonged motor distal latency and reduced compound muscle action potential (CMAP) amplitude (in severe cases).
  • Comparative Studies: Comparing median nerve latency to ulnar or radial latencies in adjacent fingers increases diagnostic sensitivity.

Australian Access & MBS

NCS are performed by neurologists, rehabilitation specialists, or suitably trained technicians. They are available in major public hospitals and private neurophysiology practices.

ℹ️
MBS Item 11000: Nerve conduction studies (not being a service to which item 11003 applies) for the investigation of a clinically suspected neuropathy or entrapment syndrome. MBS Item 11003: Includes F-wave or H-reflex studies. A GP referral is required. Bulk-billing availability varies by provider.

Ultrasound Diagnosis

High-resolution ultrasound (US) is a non-invasive, cost-effective, and dynamic imaging modality for evaluating CTS. It serves as an excellent adjunct to clinical examination and NCS.

Diagnostic Criteria

  • Cross-Sectional Area (CSA): The most reliable measure. A CSA of the median nerve >10-12 mm² at the carpal tunnel inlet (pisiform level) is highly suggestive of CTS.
  • Flattening Ratio: Increased ratio of the nerve's anteroposterior to transverse diameter within the tunnel.
  • Bowing of the Flexor Retinaculum: Indicates increased carpal tunnel pressure.
  • Nerve Vascularity: Increased intraneural vascularity (hyperaemia) on colour Doppler may be present in active inflammation.

Advantages & Limitations

    Advantages
    • Dynamic assessment (e.g., during wrist movement).
    • Visualises anatomical variants, ganglion cysts, or tenosynovitis as causes.
    • Guides accurate steroid injections.
    • No radiation, well-tolerated, quick.
    Limitations
    • Operator-dependent.
    • Does not provide functional/physiological data like NCS (e.g., conduction velocity).
    • Less useful for assessing severity in advanced neuropathy with axonal loss.

Ultrasound is particularly useful when NCS are unavailable, contraindicated, or when an alternative structural cause is suspected. It is increasingly used in Australian rheumatology and sports medicine practices.

🖼️ Carpal Tunnel Syndrome — visual summary
Carpal Tunnel Syndrome visual summary infographic

Splints & Steroid Injection (Conservative Therapy)

Wrist Splinting

First-line treatment for mild to moderate CTS. The goal is to maintain the wrist in a neutral position (0-10° extension) to minimise intracarpal pressure.

  • Use: Wear a rigid volar splint, primarily at night to prevent nocturnal flexion. Can also be worn during aggravating activities.
  • Duration: Trial for a minimum of 4-6 weeks. Continue if effective.
  • Prescription: Prefabricated splints are available over-the-counter. Custom-moulded splints from a physiotherapist or occupational therapist may be more comfortable for some patients.

Corticosteroid Injection

A highly effective intervention for providing short-to-medium term symptom relief. It reduces inflammation and oedema within the carpal tunnel.

💉
Methylprednisolone Acetate
Depo-Medrol® · Corticosteroid
Adult dose 40 mg (1 mL) as a single injection into the carpal tunnel.
Route Local infiltration (ultrasound guidance recommended).
Frequency Max 2-3 injections per year. Avoid repeated injections due to risk of tendon/fat atrophy.
PBS status ✔ PBS General Benefit
⚠️
Technique: Ultrasound guidance significantly improves accuracy and safety, reducing the risk of intraneural injection. Palpation-guided injection is acceptable if US is unavailable, but requires careful landmarking. The needle is inserted ulnar to the palmaris longus tendon, angled 30-45° distally.

Efficacy: ~70-80% of patients experience significant improvement at 8 weeks. Effect may wane over 3-12 months. A good response to injection predicts a better surgical outcome.

Surgical Decompression

Surgery is indicated for CTS refractory to conservative management, or in the presence of thenar atrophy or severe/electrophysiologically-proven neuropathy.

Surgical Techniques

Open Release
Traditional Gold Standard
A 2-3 cm incision is made in the palm. The transverse carpal ligament is divided under direct visualisation. Allows inspection of the nerve and any space-occupying lesions.
Setting: Day-case surgery, local/regional anaesthesia
Endoscopic Release
Single or Dual Portal
Uses a small endoscope and blade inserted via 1-2 small (~1 cm) incisions to divide the ligament from the inside. Potentially less post-operative pain and earlier return to function.
Setting: Day-case surgery, local/regional anaesthesia

Outcomes & Recovery

  • Success Rate: >90% of patients experience significant symptom improvement, particularly relief of nocturnal pain.
  • Recovery: Wrist splint use for 1-2 weeks. Most return to light duties in 1-2 weeks, manual work in 4-6 weeks. Grip strength may take 3-6 months to fully recover.
  • Complications: Incomplete release, nerve/vessel injury (rare with experienced surgeon), pillar pain (pain at the base of the palm), complex regional pain syndrome (rare), scar tenderness.
⚠️
Referral Criteria for Surgery: 1) Failure of 3-6 months of conservative treatment. 2) Thenar atrophy or significant weakness. 3) Severe abnormalities on NCS. 4) Patient preference after informed discussion of risks/benefits.

Special Populations

🤰 Pregnancy
CTS is common in the 2nd/3rd trimester due to fluid retention.
Usually resolves spontaneously postpartum or after cessation of breastfeeding.
Management: Primarily conservative: splints, activity modification. Avoid oral corticosteroids. Local injection can be considered in severe, refractory cases after the first trimester.
Surgery is rarely indicated and deferred until after delivery.
🧪 Diabetes Mellitus
2-3x higher prevalence. Due to metabolic changes causing endoneurial oedema and increased susceptibility to compression.
May co-exist with diabetic polyneuropathy, complicating diagnosis.
Management: NCS are essential for diagnosis. Optimal glycaemic control is important. CTS treatment is similar to the general population, but outcomes may be less favourable.
👴 Elderly
Higher prevalence of degenerative joint changes and systemic comorbidities.
May present with atypical symptoms or be less likely to report nocturnal pain.
Management: Careful assessment for other causes (cervical spondylosis, stroke). Surgery is well-tolerated and effective in the elderly, improving quality of life.
🛡️ Rheumatoid Arthritis
CTS can result from synovial proliferation within the carpal tunnel.
Management: Aggressive management of the underlying RA with DMARDs is crucial. Surgical decompression may be needed if medical therapy fails to control tenosynovitis.

Aboriginal and Torres Strait Islander Health Considerations

Considerations for Aboriginal and Torres Strait Islander Peoples
Prevalence & Risk
While specific prevalence data for CTS is limited, the higher population prevalence of key risk factors—including type 2 diabetes, obesity, and renal disease—is likely to increase the burden of CTS. Rheumatic conditions may also present differently or more severely.
Access to Care
Geographical remoteness can delay diagnosis and access to specialist services for NCS or surgical consultation. Telehealth for initial review and community-based health worker education can aid early identification.
Management Pathways
Ensure clear communication about treatment options, including the role and availability of splints and injections in community clinics. Facilitate timely referral pathways for surgery when indicated to prevent permanent disability.
Cultural Safety
Incorporate culturally safe practices, use Aboriginal Health Workers/Liaison Officers as appropriate, and be mindful of factors that may affect compliance with splint use or follow-up.
📊 Carpal Tunnel Syndrome — slide deck

Open slides PDF in new tab

📚 References

  1. 1. Padua L, Coraci D, Erra C, et al. Carpal tunnel syndrome: clinical features, diagnosis, and management. Lancet Neurol. 2016;15(12):1273-1284.
  2. 2. The Royal Australian College of General Practitioners (RACGP). Management of peripheral nerve disorders in general practice. RACGP; 2020.
  3. 3. Australian Institute of Health and Welfare (AIHW). Musculoskeletal fact sheet: Carpal tunnel syndrome. AIHW; 2023.
  4. 4. American Academy of Orthopaedic Surgeons (AAOS). Management of Carpal Tunnel Syndrome Evidence-Based Clinical Practice Guideline. AAOS; 2016.
  5. 5. Huisstede BM, Randsdorp MS, Coert JH, et al. Carpal tunnel syndrome. Part II: effectiveness of surgical treatments—a systematic review. Arch Phys Med Rehabil. 2010;91(7):1005-1024.
  6. 6. Marshall S, Tardif G, Ashworth N. Local corticosteroid injection for carpal tunnel syndrome. Cochrane Database Syst Rev. 2007;(2):CD001554.
  7. 7. Cartwright MS, Hobson-Webb LD, Boon AJ, et al. Evidence-based guideline: neuromuscular ultrasound for the diagnosis of carpal tunnel syndrome. Muscle Nerve. 2012;46(2):287-293.
  8. 8. Fernandez-de-Las-Penas C, Cleland JA, Plaza-Manzano G, et al. Clinical, physical, and neurophysiological impairments associated with decreased function in women with carpal tunnel syndrome. J Orthop Sports Phys Ther. 2013;43(9):641-649.
  9. 9. National Health and Medical Research Council (NHMRC). National Statement on Ethical Conduct in Human Research. NHMRC; 2023 (Updated). [Relevant for research context].
  10. 10. Geoghegan JM, Clark DI, Bainbridge LC, et al. Risk factors in carpal tunnel syndrome. J Hand Surg Br. 2004;29(4):315-320.
  11. 11. Department of Health. MBS Online. Australian Government; 2024. Available from: http://www.mbsonline.gov.au [Accessed for MBS item verification].